These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29883277)

  • 1. The RNA-Specific Adenosine Deaminase ADAR1 Inhibits Human Protein Kinase R Activation.
    Wang TT; Li ZG; Wang Q
    Viral Immunol; 2018 Sep; 31(7):537-538. PubMed ID: 29883277
    [No Abstract]   [Full Text] [Related]  

  • 2. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
    Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
    Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.
    Gannon HS; Zou T; Kiessling MK; Gao GF; Cai D; Choi PS; Ivan AP; Buchumenski I; Berger AC; Goldstein JT; Cherniack AD; Vazquez F; Tsherniak A; Levanon EY; Hahn WC; Meyerson M
    Nat Commun; 2018 Dec; 9(1):5450. PubMed ID: 30575730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-stranded RNA deaminase ADAR1 promotes the Zika virus replication by inhibiting the activation of protein kinase PKR.
    Zhou S; Yang C; Zhao F; Huang Y; Lin Y; Huang C; Ma X; Du J; Wang Y; Long G; He J; Liu C; Zhang P
    J Biol Chem; 2019 Nov; 294(48):18168-18180. PubMed ID: 31636123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAR1: A New Target for Immuno-oncology Therapy.
    Bhate A; Sun T; Li JB
    Mol Cell; 2019 Mar; 73(5):866-868. PubMed ID: 30849393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte-macrophage crosstalk via the PGRN-EGFR axis modulates ADAR1-mediated immunity in the liver.
    Gan WL; Ren X; Ng VHE; Ng L; Song Y; Tano V; Han J; An O; Xie J; Ng BYL; Tay DJT; Tang SJ; Shen H; Khare S; Chong KHC; Young DY; Wu B; DasGupta R; Chen L
    Cell Rep; 2024 Jul; 43(7):114400. PubMed ID: 38935501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase.
    Toth AM; Zhang P; Das S; George CX; Samuel CE
    Prog Nucleic Acid Res Mol Biol; 2006; 81():369-434. PubMed ID: 16891177
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenosine deaminase ADAR1 increases gene expression at the translational level by decreasing protein kinase PKR-dependent eIF-2alpha phosphorylation.
    Wang Y; Samuel CE
    J Mol Biol; 2009 Nov; 393(4):777-87. PubMed ID: 19733181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR.
    Toth AM; Li Z; Cattaneo R; Samuel CE
    J Biol Chem; 2009 Oct; 284(43):29350-6. PubMed ID: 19710021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAR1 Prevents Autoinflammatory Processes in the Heart Mediated by IRF7.
    Garcia-Gonzalez C; Dieterich C; Maroli G; Wiesnet M; Wietelmann A; Li X; Yuan X; Graumann J; Stellos K; Kubin T; Schneider A; Braun T
    Circ Res; 2022 Sep; 131(7):580-597. PubMed ID: 36000401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
    Nakahama T; Kawahara Y
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.
    Li Z; Okonski KM; Samuel CE
    J Virol; 2012 Apr; 86(7):3787-94. PubMed ID: 22278222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the potential function of ADAR1 in virus-associated sepsis.
    Zhuang Y; Peng H; Chen Y; Zhou S; Chen Y
    Front Biosci (Landmark Ed); 2017 Mar; 22(8):1355-1364. PubMed ID: 28199207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAR1 Regulates Early T Cell Development via MDA5-Dependent and -Independent Pathways.
    Vongpipatana T; Nakahama T; Shibuya T; Kato Y; Kawahara Y
    J Immunol; 2020 Apr; 204(8):2156-2168. PubMed ID: 32169840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAR1: "Editor-in-Chief" of Cytoplasmic Innate Immunity.
    Lamers MM; van den Hoogen BG; Haagmans BL
    Front Immunol; 2019; 10():1763. PubMed ID: 31404141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
    Liddicoat BJ; Chalk AM; Walkley CR
    Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.
    George CX; Li Z; Okonski KM; Toth AM; Wang Y; Samuel CE
    J Interferon Cytokine Res; 2009 Sep; 29(9):477-87. PubMed ID: 19715457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAR1 and PACT contribute to efficient translation of transcripts containing HIV-1 trans-activating response (TAR) element.
    Chukwurah E; Handy I; Patel RC
    Biochem J; 2017 Mar; 474(7):1241-1257. PubMed ID: 28167698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade.
    Ishizuka JJ; Manguso RT; Cheruiyot CK; Bi K; Panda A; Iracheta-Vellve A; Miller BC; Du PP; Yates KB; Dubrot J; Buchumenski I; Comstock DE; Brown FD; Ayer A; Kohnle IC; Pope HW; Zimmer MD; Sen DR; Lane-Reticker SK; Robitschek EJ; Griffin GK; Collins NB; Long AH; Doench JG; Kozono D; Levanon EY; Haining WN
    Nature; 2019 Jan; 565(7737):43-48. PubMed ID: 30559380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.